Target intelligence / Profile preview

EXOC3 antisense RNA 1 (EXOC3-AS1)

Target
EXOC3-AS1
Molecular classification
Long noncoding RNA, Antisense RNA, Natural antisense transcript, Other
01

Overview

EXOC3 antisense RNA 1 (EXOC3-AS1) is a long noncoding RNA (lncRNA) transcribed from the antisense strand relative to the EXOC3 gene. Like other antisense RNAs, EXOC3-AS1 is thought to participate in the regulation of gene expression, potentially impacting transcription, mRNA stability, or translation through interactions with its corresponding sense strand or associated chromatin regions[1][2][3]. Antisense lncRNAs often modulate gene function in either cis (locally) or trans (distantly) and have been implicated in diverse processes such as epigenetic regulation, RNA processing, and the modulation of cell signaling pathways[1][2]. While the specific biological role of EXOC3-AS1 is not yet fully characterized, similar antisense RNAs have been shown to influence disease processes, especially in cancer, by controlling the expression of genes associated with cell proliferation, drug resistance, and cell death[1]. EXOC3-AS1 has no documented interacting drugs, mechanisms of action for pharmacological targeting, or current biomarker status. Its function and disease associations remain the subject of ongoing basic research[3][4].

Other names
EXOC3-AS1C5orf55EXOC3 antisense gene protein 1Uncharacterized protein EXOC3-AS1
02

Biological functions

Regulation of gene expressionEpigenetic regulationRNA-mediated modulationPossible involvement in alternative splicing
03

Disease associations

Cancer (potential role as indicated for other antisense lncRNAs)Other

Beyond the preview

Go deeper on EXOC3 antisense RNA 1 (EXOC3-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EXOC3 antisense RNA 1 (EXOC3-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call